InspireMD, Inc. (NSPR:NASDAQ) closed at $0.450 on October 26, 2026, up 0.16% on the day. The stock trades 81.3% below its 52-week high of $2.41 and 4.7% above its 52-week low of $0.430. Over the past year, it lost 80.1%. InspireMD, Inc. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, NSPR closed higher on 90 days (36%). Its best day was August 14, 2026 (+16.67%) and its worst was November 20, 2025 (-11.46%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.
InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.
Find more stocks like NSPR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.